VILLA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 2.688
AS - Asia 2.155
EU - Europa 1.899
SA - Sud America 347
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 56
OC - Oceania 12
Totale 7.262
Nazione #
US - Stati Uniti d'America 2.558
IT - Italia 967
SG - Singapore 624
VN - Vietnam 484
CN - Cina 422
BR - Brasile 268
HK - Hong Kong 223
RU - Federazione Russa 194
DE - Germania 157
FR - Francia 95
CA - Canada 82
IE - Irlanda 78
BD - Bangladesh 73
GB - Regno Unito 73
SE - Svezia 70
IN - India 67
KR - Corea 55
ID - Indonesia 50
FI - Finlandia 41
NL - Olanda 41
ES - Italia 37
CH - Svizzera 31
PL - Polonia 28
AR - Argentina 27
AT - Austria 26
JP - Giappone 23
TR - Turchia 23
MX - Messico 19
PH - Filippine 18
ZA - Sudafrica 18
IQ - Iraq 15
EC - Ecuador 14
UA - Ucraina 13
LT - Lituania 12
PK - Pakistan 12
MA - Marocco 11
VE - Venezuela 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
AU - Australia 8
KE - Kenya 8
PE - Perù 8
BE - Belgio 7
CL - Cile 7
CR - Costa Rica 7
TH - Thailandia 6
CO - Colombia 5
EG - Egitto 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
GR - Grecia 3
HN - Honduras 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
Totale 7.154
Città #
Milan 344
Singapore 344
Ashburn 342
San Jose 310
Hong Kong 207
Dallas 192
Ho Chi Minh City 145
Hanoi 139
Los Angeles 102
Hefei 100
Ann Arbor 97
New York 94
Frankfurt am Main 79
Dublin 76
Beijing 62
Council Bluffs 61
Santa Clara 51
Seoul 51
Chicago 50
Columbus 48
The Dalles 38
Jakarta 37
Rome 37
Munich 35
Toronto 35
Chandler 33
Boardman 30
Buffalo 29
Phoenix 29
São Paulo 29
Staranzano 27
Desio 26
Lauterbourg 26
Moscow 25
Montreal 24
Zurich 24
Seveso 22
Fairfield 20
Helsinki 20
London 20
Kent 19
Tokyo 19
Warsaw 18
Monza 17
Da Nang 16
Denver 16
Houston 16
Turku 16
Carate Brianza 15
Chennai 15
Haiphong 15
Stockholm 15
Atlanta 14
Brooklyn 14
Nuremberg 14
Orem 14
Lissone 13
Shanghai 13
Turin 13
Poplar 12
Seattle 12
Vienna 12
Amsterdam 11
Genoa 11
Johannesburg 11
Paris 11
Rio de Janeiro 11
Boston 10
Ha Long 10
Perugia 10
Tashkent 10
Figino 9
Ankara 8
Biên Hòa 8
Can Tho 8
Lima 8
Manchester 8
Philadelphia 8
Quezon City 8
Sesto San Giovanni 8
The Bronx 8
Wilmington 8
Brescia 7
Brussels 7
Campinas 7
Cesano Maderno 7
Ithaca 7
Naples 7
Newark 7
Pune 7
Quận Bình Thạnh 7
Quận Một 7
San Diego 7
Seregno 7
Baghdad 6
Concord 6
Corsico 6
Curitiba 6
Florence 6
Forsyth 6
Totale 4.092
Nome #
Investigation of drug resistance and co-mutational landscape of ALK-positive tumors 488
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 451
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 431
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 392
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 378
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 364
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 335
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 317
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 311
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 306
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 305
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 301
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 298
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 287
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 275
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 255
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 254
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 250
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 242
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 220
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 197
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 173
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 163
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 127
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution 90
Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations 52
Totale 7.262
Categoria #
all - tutte 20.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/20251.551 52 94 88 78 105 58 98 43 181 255 156 343
2025/20263.897 485 322 402 496 365 182 517 148 255 350 135 240
2026/2027904 206 260 427 11 0 0 0 0 0 0 0 0
Totale 7.262